What can Big Pharma learn from an NYT bestseller?

What do blockbuster drugs have in common with Harry Potter and Lisbeth Salander? They're all mega-sellers in industries in which only two of every 7 big, risky bets pans out. So, Big Pharma could learn a trick or two from publishers, the Financial Times posits. Report

Suggested Articles

With U.S. presidential and congressional campaigns in full swing, it’s not just Americans anxiously awaiting the results of the upcoming elections.

Sun Pharma has recalled one lot of its generic metformin after finding high levels of the probable carcinogen NDMA in tested lots.

Six months after WHO declared a pandemic, the list of drugs proven to work against the virus remains short. Now, Fujifilm has added its drug Avigan.